Eloxx Pharmaceuticals Inc (OQ:ELOX)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ELOX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 1st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 26/20 May 20/20 Rubin Steven D Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Pontifax Management 4 G.P. (2015) Ltd. Indirect Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Pontifax Management 4 G.P. (2015) Ltd. Indirect Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Seehra Jasbir Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Veinrib Gadi Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Kariv Tomer Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Avnur Zafrira Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Noiman Silvia Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Nussbaum Ran Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Kleijwegt Martijn Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ELOX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 1st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 26/20 May 20/20 Rubin Steven D Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Pontifax Management 4 G.P. (2015) Ltd. Indirect Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Pontifax Management 4 G.P. (2015) Ltd. Indirect Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Seehra Jasbir Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Veinrib Gadi Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Kariv Tomer Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Avnur Zafrira Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Noiman Silvia Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Nussbaum Ran Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
May 22/20 May 20/20 Kleijwegt Martijn Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ELOX

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)